(Q28184349)

https://api.crossref.org/works/10.1081/CNV-120018821

Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

AML1 is expressed in skeletal muscle and is regulated by innervation

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Genomic characterization of the human trkC gene

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

AML1 (CBFalpha2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Regulatory and signaling properties of the Vav family

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Unregulated activation of STAT-5, ERK1/2 and c-Fos may contribute to the phenotypic transformation from myelodysplastic syndrome to acute leukaemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

HERF1, a novel hematopoiesis-specific RING finger protein, is required for terminal differentiation of erythroid cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

The CBP co-activator is a histone acetyltransferase

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

The mammalian basic helix loop helix protein HES-1 binds to and modulates the transactivating function of the runt-related factor Cbfa1

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Mutation and cancer: statistical study of retinoblastoma

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Two genetic hits (more or less) to cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Bcl-G, a novel pro-apoptotic member of the Bcl-2 family

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

MKP-7, a novel mitogen-activated protein kinase phosphatase, functions as a shuttle protein

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Early signaling pathways activated by c-Kit in hematopoietic cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

The genetics of familial leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

The Ikaros gene is required for the development of all lymphoid lineages

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

t(8;21) myelodysplasia, an early presentation of M2 AML

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

FMS mutations in myelodysplastic, leukemic, and normal subjects

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia

21 April 2017

1 reference

https://api.crossref.org/works/10.1081/CNV-120018821

Transcriptional control by the TGF-beta/Smad signaling system

21 April 2017

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

A breakpoint map of recurrent chromosomal rearrangements in human neoplasia

21 April 2017

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Leukaemia/Drosophila homology

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2/CBF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Transcription-coupled translation control of AML1/RUNX1 is mediated by cap- and internal ribosome entry site-dependent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

The RUNX3 gene--sequence, structure and regulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor delta and murine leukemia virus enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Cooperative binding of Ets-1 and core binding factor to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Requirement of Runx1/AML1/PEBP2alphaB for the generation of haematopoietic cells from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

AML1, the target of chromosomal rearrangements in human leukemia, regulates the expression of human complement receptor type 1 (CR1) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Structural and functional characterization of the human CD36 gene promoter: identification of a proximal PEBP2/CBF site

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Polyomavirus enhancer-binding protein 2/core binding factor/acute myeloid leukemia factors contribute to the cell type-specific activity of the CD11a integrin gene promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Regulation of the vav proto-oncogene by LKLF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

The AML1/ETO fusion protein activates transcription of BCL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Genomic organization and regulation of the vav proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Histone acetylation: chromatin in action

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Groucho-dependent and -independent repression activities of Runt domain proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

C/EBPalpha and G-CSF receptor signals cooperate to induce the myeloperoxidase and neutrophil elastase genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Regulation of the myeloperoxidase enhancer binding proteins Pu1, C-EBP alpha, -beta, and -delta during granulocyte-lineage specification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Dichotomy of AML1-ETO functions: growth arrest versus block of differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

CCAAT/enhancer-binding protein-alpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Chromosome segregation and cancer: cutting through the mystery

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

The murine gene p27Kip1 is haplo-insufficient for tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Accommodating haploinsufficient tumor suppressor genes in Knudson's model

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Lack of TEL/AML1 fusion in pediatric AML: further evidence for lineage specificity of TEL/AML1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

The TEL-AML1 fusion accompanied by loss of the untranslocated TEL allele in B-precursor acute lymphoblastic leukaemia of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

p27KIP1 deletions in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Translocation (3;21) in Philadelphia chromosome-positive chronic myelogenous leukemia prior to the onset of blast crisis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Translocation t(3;21)(q26;q22) in acute myeloblastic leukemia secondary to polycythemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Translocation (3;21)(q26;q22) in therapy-related myelodysplasia following drugs targeting DNA-topoisomerase II combined with alkylating agents, and in myeloproliferative disorders undergoing spontaneous leukemic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

The EVI1 gene in myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Inhibition of the transforming growth factor beta 1 signaling pathway by the AML1/ETO leukemia-associated fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hematopoietic cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Lineage specificity of CBFA2 fusion transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Acute lymphoblastic leukemia and chromosome 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Molecular tracking of leukemogenesis in a triplet pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

STAT3 activation is required for Asp(816) mutant c-Kit induced tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Induction of apoptosis in myeloid leukaemic cells by ribozymes targeted against AML1/MTG8

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Ribonuclease H attack of leukaemic fused transcripts AML1-MTG8 (ETO) by DNA/RNA chimeric hammerhead ribozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Cleavage of AML1/MTG8 by asymmetric hammerhead ribozymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Locus of the alpha-chain of the T-cell receptor is split by chromosome translocation in T-cell leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

A conserved tissue-specific structure at a human T-cell receptor beta-chain core promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Human gamma-chain genes are rearranged in leukaemic T cells and map to the short arm of chromosome 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Regulation of the T-cell receptor delta enhancer by functional cooperation between c-Myb and core-binding factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

A hematopoietic-specific transmembrane protein, Art-1, is possibly regulated by AML1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

The genomic structure and chromosomal localization of the mouse STAT3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Identification of human granzyme B promoter regulatory elements interacting with activated T-cell-specific proteins: implication of Ikaros and CBF binding sites in promoter activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Spi-1/PU.1 transgenic mice develop multistep erythroleukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Impaired energy homeostasis in C/EBP alpha knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Cytogenetic characteristics of therapy-related acute nonlymphocytic leukaemia, preleukaemia and acute myeloproliferative syndrome: correlation with clinical data for 61 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Identification of two new translocations that disrupt the AML1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

t(4;21) (p16;q22) in blastic crisis of a chronic myeloid leukemia with variant Philadelphia translocation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

AML with unusual chromosomal changes. Translocation (15;21) and 5q- in the presence of two normal chromosomes 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

A t (11;21) (13;q22) in Ph-positive chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Spectral karyotyping (SKY) refinement of a complex karyotype with t(20;21) in a Ph-positive CML patient submitted to peripheral blood stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Acute myeloid leukemia with translocation (8;21). Cytomorphology, dysplasia and prognostic factors in 41 cases. AML Cooperative Group and ECOG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Hematological features and treatment outcome in acute myeloid leukemia with t(8;21).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

First report of t(8;21)(q22;q22) in a case of de novo acute monoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

8;21 translocation and multilineage involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

ONCOGENESIS: Landscaping the Cancer Terrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Bone and haematopoietic defects in mice lacking c-fos

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821

Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120018821